BDBM350521 1-(4-chlorophenyl)-3-(4-ethyl-4- methyl-2,5-dioxoimidazolidin-1- yl)urea::US10208071, Table 2.2::US10434112, Table 2.2::US10799518, Structure TABLE 2.2

SMILES CCC1(C)NC(=O)N(NC(=O)Nc2ccc(Cl)cc2)C1=O

InChI Key InChIKey=ZGKLRHHWQLBTCW-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350521   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350521(1-(4-chlorophenyl)-3-(4-ethyl-4- methyl-2,5-dioxoi...)
Affinity DataEC50:  1.57E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350521(1-(4-chlorophenyl)-3-(4-ethyl-4- methyl-2,5-dioxoi...)
Affinity DataEC50:  157nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350521(1-(4-chlorophenyl)-3-(4-ethyl-4- methyl-2,5-dioxoi...)
Affinity DataEC50:  157nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent